Hax pairs with Johnson & Johnson to create personal care accelerator programme

By Natasha Spencer

- Last updated on GMT

Hax and Johnson & Johnson create personal care accelerator programme

Related tags: Johnson & johnson

China-based Hax, which specialises in providing seed investment for hardware startups, has joined forces with personal care giant Johnson & Johnson to create a new acceleration initiative.

Johnson & Johnson Innovation, which aims to  develop healthcare solutions that encourage idea-sharing and required support, teams up with the Hax development programme to harness new technology concepts for the personal care sector.

The partnership will co-accelerate consumer healthcare-related companies and their technologies at Hax’s hardware programme located in Shenzhen, Guangdong Province, China.

Innovative technology initiative

Building on the renowned experience and recognised market leader of Johnson and Johnson and Hax’s active investment position, the programme, named ‘Health Track’, aims to provide support and help propel start-ups relevant to Johnson & Johnson’s key sectors including skin care products and technologies.

The hardware accelerator will provide startup companies with mentoring, information and networking opportunities, along with offering early-stage seed funding and office space. Johnson & Johnson and Hax will also provide all aspects of strategy management including prototyping, sourcing, supply chain, marketing and PR.

In turn, the chosen startups will give an agreed amount of equity to Hax and Johnson & Johnson to propel their commercialisation and growth.

Smart investment

As bridging the gap between technology and people is high on the agenda for personal care brands, market company Mintel reports that augmented human will be a key trend over the current forecast period through to 2025.

The sector, as a whole, will focus R&D and innovations on smart technologies that equip consumers with increased control over product choice and regimes.

Personal care conglomerate, Johnson & Johnson, has prioritised investment in new technology in recent years. In 2014, the company invested $20 mn (€18.98 mn) in startup La Lumiere, the illuMask developer, which provided consumers with an innovative wearable light therapy mask.

Hax and Johnson & Johnson’s startup programme, which is now open for entries until 21st December 2016, will commence in Spring 2017.

The duo’s programme requires the successful applicants to build and show a proof-of-concept prototype, before relocating to Shenzhen, China for the entirety of the programme.

Related news

Show more

Related products

show more

Change the Game with Water-Soluble Salicylic Acid!

Change the Game with Water-Soluble Salicylic Acid!

Tagra Biotechnologies | 28-Oct-2019 | Product Presentation

Watch Tagra’s Water Soluble Salicylic Acid WS SA50TM how-to video to see how to make alcohol-free formulas, sensitive skin formulas, and many more! WS...

BODY'licious, when body becomes the new face!

BODY'licious, when body becomes the new face!

SEPPIC | 21-Oct-2019 | Technical / White Paper

Seppic presents its new body care formulas collection: BODY’licious. Consumers are getting more demanding in terms of body product sensoriality and functionality:...

Microbiome-friendly long lasting deo

Microbiome-friendly long lasting deo

Symrise | 11-Oct-2019 | Product Brochure

SymDeo® B125 is a patented and simple aliphatic alcohol. It supports especially long lasting protection against body odor. While deodorants alone are typically...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars

Indie Pioneers Podcast

Indie Pioneers Podcast